Current View: Ongoing Studies
Acute Coronary Syndrome
Recent Heart Attack
(7/1/2008 - ongoing) Phase III. Evaluating the
effect of an Investigational Product on cardiovascular (CV) risk in stable CHD patients, with a
documented recent Acute Coronary Syndrome (ACS). Males and Females, 45 years of age and older, who have experienced a “cardiac event” within the past 8 weeks.
Asthma
(10/1/2009 - ongoing) Phase III. Evaluating the effect of an Investigational Product in atopic asthmatics with good lung capacity. Males and Females, 12 to 75 years of age, with allergy induced asthma.
Atrial Fibrillation
(7/1/2008 - ongoing) Phase III. Evaluating efficacy and safety of Investigational Product in preventing cardiac events in subjects with Atrial Fibrillation. Males and Females, 18 years of age and older, with Atrial Fibrillation or Flutter and cardiac risk factors.
COPD
(7/1/2009 - ongoing) Phase III. Evaluating the safety, efficacy and tolerability of Investigational Product in patients with moderate to severe COPD. Males and Females, 40 years of age and older, who have been diagnosed with COPD or Chronic Obstructive Pulmonary Disease.
Diabetes (Type II)
(12/1/2008 - ongoing) Phase III. Evaluating the efficacy and safety of Investigational Product as monotherapy in patients with Type II Diabetes. Males and Females, 18 years of age and older, with Type II Diabetes that are not taking diabetic medication.
(10/25/2008 - ongoing) Phase III. A study to evaluate the efficacy and safety of Investigational Product with Metformin in patients with Type II Diabetes. Males and Females, 18 to 78 years of age, with Type II Diabetes that are taking Metformin and looking for additional therapy.
Hot Flashes
Post-Menopausal Symptoms
(2/9/2009 - ongoing) Phase III. A efficacy and safety study to evaluate hte effect of Investigational Product on Endometrial Hyperplasia and Osteoporosis prevention. Postmenopausal Females, 40 to 65 years of age, with menopausal symptoms.
Low Sodium
(2/1/2010 - ongoing) Phase III. International, Multicenter, Study of a Twenty-Eight Week,
Open-Label, Titrated Oral Investigational Product in
Patients with Chronic Hyponatremia: Extension to Core Study.
Males and Females, 18 years of age and older, with low sodium levels and have completed the core low sodium trial (described above).
Osteoarthritis
(9/1/2007 - ongoing) Phase III. Evaluating safety and efficacy of Investigational Product in subjects with Osteoarthritis of the Knee. Males and Females, 40 years of age and older, with Osteoarthritis of the Knee.
Osteoporosis
(10/1/2008 - ongoing) Phase III. An Extension Osteoporosis trial to evaluate the efficacy and long term safety of Investigational Product in postmenopausal women with Osteoporosis. Females with Osteoporosis who have completed the Core and Extension 1 Osteoporosis trial.
Study 1
(7/22/2009 - ongoing) Phase III.
Post menopausal females, 55 years of age and older, with Osteoporosis.